LON:GUN Gunsynd 12/5/2024 Earnings Report GBX 0.10 +0.01 (+6.59%) As of 05/8/2026 11:32 AM Eastern ProfileEarnings History Gunsynd EPS ResultsActual EPS-GBX 0.17Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AGunsynd Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AGunsynd Announcement DetailsQuarterDate12/5/2024TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Gunsynd Earnings HeadlinesGunsynd prepares expanded summer exploration campaign at Barb Gold ProjectMay 7 at 2:02 AM | uk.finance.yahoo.comGunsynd to start summer field programme at Barb projectMay 7 at 2:02 AM | lse.co.ukSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.May 10 at 1:00 AM | Brownstone Research (Ad)Gunsynd Secures Full Shareholder Backing at 2026 AGMMarch 25, 2026 | tipranks.comGunsynd Set to Benefit as Canada Advances Mackenzie Valley HighwayMarch 18, 2026 | tipranks.comAIM WINNERS & LOSERS: Proteome Sciences wins contracts; Gunsynd fallsJanuary 6, 2026 | lse.co.ukSee More Gunsynd Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Gunsynd? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Gunsynd and other key companies, straight to your email. Email Address About GunsyndGunsynd (LON:GUN) is a private equity firm that specializes in buyout and project investments. The firm seeks to invest in natural resource and energy sector. The firm may make investments in all types of assets and there will be no investment restrictions on the type of investment that the company might make or the type of opportunity that may be considered. It seeks to invest specifically in Europe; however, it can consider investments in other regions if they are considered to be profitable by the board. The Firm may take any possible opportunity in the world. It also specializes in direct acquisitions, farm-ins, partnerships; earn in joint ventures, debt of other loan structures, joint ventures direct or indirect interests in assets of projects. The firm might seek the both, minority and majority stake position in its investments and can indulge in multiple investments. The average holding period of the firm's investments is generally for medium to long term range, however it can also dispose its assets if there is an opportunity to make shareholders value. The firm may be active of passive investor depending upon the situation. The firm was formerly known as Evocutis plc and changed its name to Gunsynd Plc in August 2016. Gunsynd Plc was founded in 2005 and is based in London, the United Kingdom.View Gunsynd ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 05/04 - 05/08Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major PlayersRocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance3 Under-The-Radar Small Caps Making New All-Time HighsFlutter Sees Post-Earnings Boost as FanDuel Shows Signs of RecoveryHims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusWater Infrastructure: Why This Boring Sector Could Get Exciting Upcoming Earnings Constellation Energy (5/11/2026)Barrick Mining (5/11/2026)Petroleo Brasileiro S.A.- Petrobras (5/11/2026)Simon Property Group (5/11/2026)SEA (5/12/2026)Cisco Systems (5/13/2026)Alibaba Group (5/13/2026)Manulife Financial (5/13/2026)Sumitomo Mitsui Financial Group (5/13/2026)Takeda Pharmaceutical (5/13/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.